（文章来源：证券日报） 证券日报网讯 9月4日晚间，恒实科技发布公告称，公司第三届董事会第六十五次会议审议通过了《关 于拟出售参股公司部分股份的议案》。 ...

Group 1: Company Announcements - Heng Rui Medicine has received the clinical trial approval notice for HRS-4729 injection, a self-developed peptide drug targeting GLP-1R, GIPR, and GCGR receptors, with no similar products approved in the market [1] - Hubei Yihua has successfully launched its 200,000 tons/year caustic soda project, aimed at upgrading its chlor-alkali chemical industry and enhancing market competitiveness [2] - Ji Min Health announced that its shareholder, Shuangge Group, plans to reduce its stake by up to 3%, equating to a maximum of 15.75 million shares [3] - China Shipbuilding intends to absorb and merge with China Shipbuilding Industry Corporation through a share exchange, with the latter's A-shares set to be delisted on September 5, 2025 [4] - Changfei Fiber reported that its shareholder, Changjiang Communication, plans to reduce its stake by up to 0.15%, totaling no more than 1.1 million shares [5] Group 2: Strategic Collaborations and Developments - Beijing Lier has signed a strategic cooperation agreement with SenseTime and Xiwang Technology to explore AI computing power collaboration and related applications [6] - Junsheng Electronics is collaborating with leading clients like Zhiyuan Robotics, having achieved bulk supply of customized main control boards and various sensors [7][8] - Guoxin Technology has successfully tested a new generation of high-performance chips for automotive electronic BLDC motor control, aimed at addressing the MCU chip shortage in the automotive sector [9] Group 3: Other Corporate Actions - Guoguang Chain's actual controller plans to reduce their stake by up to 2.99%, totaling a maximum of 12.506 million shares [10] - Zhonghuan Hailu has terminated its control change plan, with its stock set to resume trading on September 5, 2025 [11] - Various companies have reported significant project wins, including Ningbo Construction winning contracts worth 1.117 billion yuan [12]

Core Viewpoint - Hengshi Technology announced plans to sell part of its stake in Beijing Qianjing Wuyou Electronic Technology Co., Ltd. to improve its financial situation and alleviate funding pressure [2] Summary by Relevant Sections - **Transaction Details** - The company plans to transfer 11,880,000 shares of Beijing Qianjing Wuyou, with a total transfer price of RMB 109,296,000 [2] - Prior to the transfer, the company held 28,650,000 shares, representing 26.53% of the total share capital of Qianjing Wuyou [2] - After the transfer, the company will hold 16,770,000 shares, which will account for 15.53% of the total share capital [2] - **Board Meeting** - The third session of the third board meeting was held on September 3, 2025, where the proposal for the share transfer was approved [2] - The transaction does not require approval from the company's shareholders' meeting [2]

Core Viewpoint - Hengshi Technology (300513.SZ) aims to improve its financial situation and alleviate funding pressure by signing a share transfer agreement to sell shares in its associate company, Beijing Qianjing Wuyou Electronic Technology Co., Ltd. [1] Financial Details - The company plans to transfer a total of 11,880,000 shares at a total price of RMB 109,296,000 [1] - Before the transfer, the company held 28,650,000 shares in Qianjing Wuyou, accounting for 26.53% of its total share capital [1] - After the transfer, the company will hold 16,770,000 shares, which will represent 15.53% of the total share capital [1]

格隆汇9月4日丨恒实科技(300513.SZ)公布，为改善财务状况，缓解资金压力，拟与锦绣中和（北京） 资本管理有限公司、河北立中有色金属集团有限公司、刘振东、戴元永、杨宝林、汪淑涓、张敬庭签署 《股份转让协议》，拟转让参股公司北京前景无忧电子科技股份有限公司（简称"前景无忧"或"标的公 司"）11,880,000股股份，转让价格总计人民币109,296,000元。本次转让前公司持有前景无忧28,650,000 股，占其总股本比例为26.53%，转让后公司持有前景无忧16,770,000股，占其总股本比例为15.53%。 ...

Group 1 - The company plans to sign a share transfer agreement to transfer 11.88 million shares of Beijing Qianjing Wuyou Electronic Technology Co., Ltd. for a total price of 109 million RMB [1] - After the transfer, the company will hold 16.77 million shares of Qianjing Wuyou, accounting for 15.53% of its total share capital [1] - This transaction is expected to increase the company's operating capital, providing financial support for business expansion and promoting stable development [1]

恒实科技（300513）(300513.SZ)公告，公司拟与锦绣中和(北京)资本管理有限公司、河北立中有色金属 集团有限公司、刘振东、戴元永、杨宝林、汪淑涓、张敬庭签署《股份转让协议》，拟转让参股公司北 京前景无忧电子科技股份有限公司(简称"前景无忧")1188万股股份，转让价格总计人民币1.09亿元。转 让后公司持有前景无忧1677万股，占其总股本比例为15.53%。本次交易有利于增加公司营运资金，为 公司业务拓展提供资金支持，促进公司稳健发展。 ...

恒实科技公告，公司计划以1.09亿元的价格转让所持有的前景无忧1188万股股份，占其总股本比例为 15.53%。交易完成后，恒实科技将继续持有前景无忧1677万股，占其总股本比例为15.53%。此次交易 旨在改善财务状况和缓解资金压力，预计将增加公司营运资金，为业务拓展提供资金支持，促进公司稳 健发展。 ...

证券代码：300513 证券简称：恒实科技 公告编号：2025-034 北京恒泰实达科技股份有限公司 第三届董事会第六十五次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 1、本次董事会会议通知于 2025 年 9 月 3 日以电话、口头通知等方式发出。 2、本次董事会于 2025 年 9 月 3 日以通讯会议方式召开，并采取通讯表决方 式进行表决。 表决结果：通过。 3、本次会议应出席董事 8 名，实际出席董事 8 名。 4、本次会议由董事长钱苏晋先生主持，公司董事会秘书、监事及高级管理 人员列席了本次会议。 5、本次董事会会议的召开符合有关法律、行政法规、部门规章、规范性文 件和公司章程的规定，合法有效。 二、董事会会议审议情况 1、审议通过《关于拟出售参股公司部分股份的议案》 公司为改善财务状况，缓解资金压力，拟与锦绣中和（北京）资本管理有限 公司、河北立中有色金属集团有限公司、刘振东、戴元永、杨宝林、汪淑涓、张 敬庭签署《股份转让协议》，拟转让参股公司北京前景无忧电子科技股份有限公 司（以下简称"前景无忧"）11, ...

证券代码：300513 证券简称：恒实科技 公告编号：2025-035 北京恒泰实达科技股份有限公司 关于拟出售参股公司部分股份的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、交易概述 北京恒泰实达科技股份有限公司（以下简称"恒实科技"或"公司"）为改 善财务状况，缓解资金压力，拟与锦绣中和（北京）资本管理有限公司、河北立 中有色金属集团有限公司、刘振东、戴元永、杨宝林、汪淑涓、张敬庭签署《股 份转让协议》，拟转让参股公司北京前景无忧电子科技股份有限公司（以下简称 "前景无忧"或"标的公司"）11,880,000股股份，转让价格总计人民币 109,296,000元。本次转让前公司持有前景无忧28,650,000股，占其总股本比例 为26.53%，转让后公司持有前景无忧16,770,000股，占其总股本比例为15.53%。 公司于2025年9月3日召开第三届董事会第六十五次会议，审议通过了《关于 拟出售参股公司部分股份的议案》，根据《深圳证券交易所创业板股票上市规则》 《公司章程》等相关规定，本次交易事项无需提交公司股东大会审议。 根据《深圳证券交易 ...